Concepedia

Maria Mazurkiewicz-Bełdzińska

MM

Statistics

Publications

7

Citations

477

H-Index

7

Active since

2020

Affiliations

Gdańsk Medical University(Current)

Roche (Switzerland)

Pirogov Russian National Research Medical University

University College London

Fondazione IRCCS Istituto Neurologico Carlo Besta

Maria Mazurkiewicz-Bełdzińska is an author at Gdańsk Medical University specializing in spinal muscular atrophy, spinal muscular atrophy pharmacotherapy, and neurology.

Publications per year

2020–2025

7

Publications

7

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

Basil T. Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska et al. · New England Journal of Medicine · 2021 · 274 citations · Full text

, , +17

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 104 citations · Full text

, , +6

Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study

Claude Cancés, D. Vlodavets, Riccardo Masson et al. · Orphanet Journal of Rare Diseases · 2022 · 35 citations · Full text

, , +16

FIREFISH Part 2: Efficacy and Safety of Risdiplam (RG7916) in Infants with Type 1 Spinal Muscular Atrophy (SMA) (1302)

Laurent Servais, Giovanni Baranello, Riccardo Masson et al. · Neurology · 2020 · 26 citations

, , +11

Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy

Sylwia Studzińska, Jakub Szymarek, Maria Mazurkiewicz-Bełdzińska · Talanta · 2023 · 15 citations

, , +3

1–5 of 7